TipRanks
Teva Pharmaceutical Industries Limited (TEVA)
NYSE:TEVA
US Market
Want to see TEVA full AI Analyst Report?

Teva (TEVA) Financial Statements

44 Followers

Teva Financial Overview

Teva's market cap is currently $45.65B. The company's EPS TTM is $0.63; its P/E ratio is 68.52; and it has a dividend yield of 5.80%. Teva is scheduled to report earnings on July 29, 2026, and the estimated EPS forecast is $0.72. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 18.68B$ 16.54B$ 15.85B$ 14.93B$ 15.88B
Gross Profit$ 9.63B$ 8.06B$ 7.65B$ 6.97B$ 7.59B
Operating Income$ 4.28B$ -303.00M$ 433.00M$ -2.10B$ 1.72B
EBITDA$ 3.34B$ 777.00M$ 1.56B$ -925.00M$ 2.88B
Net Income$ 1.53B$ -1.64B$ -559.00M$ -2.35B$ 417.00M
Balance Sheet
Cash & Short-Term Investments$ 3.56B$ 3.30B$ 3.23B$ 2.80B$ 2.17B
Total Assets$ 40.76B$ 39.33B$ 43.48B$ 44.01B$ 47.67B
Total Debt$ 17.39B$ 18.08B$ 20.15B$ 21.56B$ 23.46B
Net Debt$ 13.83B$ 14.78B$ 16.93B$ 18.76B$ 21.29B
Total Liabilities$ 32.84B$ 33.61B$ 35.35B$ 35.31B$ 36.42B
Stockholders' Equity$ 7.91B$ 5.37B$ 7.51B$ 7.90B$ 10.28B
Cash Flow
Free Cash Flow$ 2.56B$ 749.00M$ 842.00M$ 1.04B$ 236.00M
Operating Cash Flow$ 3.10B$ 1.25B$ 1.37B$ 1.59B$ 798.00M
Investing Cash Flow$ -557.47M$ 792.00M$ 968.00M$ 656.00M$ 1.52B
Financing Cash Flow$ -2.29B$ -1.79B$ -1.91B$ -1.49B$ -2.17B
Currency in USD

Teva Earnings and Revenue History

Teva Debt to Assets

Teva Cash Flow

Teva Forecast EPS vs Actual EPS